Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 2. Idiopathic Pulmonary Fibrosis / 결핵
Tuberculosis and Respiratory Diseases
;
: 102-117, 2019.
Article
in English
| WPRIM
| ID: wpr-742452
ABSTRACT
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive fibrosing interstitial pneumonia, which presents with a progressive worsening dyspnea, and thus a poor outcome. The members of the Korean Academy of Tuberculosis and Respiratory Diseases as well as the participating members of the Korea Interstitial Lung Disease Study Group drafted this clinical practice guideline for IPF management. This guideline includes a wide range of topics, including the epidemiology, pathogenesis, risk factors, clinical features, diagnosis, treatment, prognosis, and acute exacerbation of IPF in Korea. Additionally, we suggested the PICO for the use of pirfenidone and nintendanib and for lung transplantation for the treatment of patients with IPF through a systemic literature review using experts' help in conducting a meta-analysis. We recommend this guideline to physicians, other health care professionals, and government personnel in Korea, to facilitate the treatment of patients with IPF.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Prognosis
/
Tuberculosis
/
Epidemiology
/
Risk Factors
/
Lung Transplantation
/
Lung Diseases, Interstitial
/
Disease Management
/
Delivery of Health Care
/
Diagnosis
/
Dyspnea
Type of study:
Diagnostic study
/
Etiology study
/
Practice guideline
/
Prognostic study
/
Risk factors
/
Systematic reviews
Limits:
Humans
Country/Region as subject:
Asia
Language:
English
Journal:
Tuberculosis and Respiratory Diseases
Year:
2019
Type:
Article
Similar
MEDLINE
...
LILACS
LIS